Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Devon is a deep-value buy in 2024, with strong upside potential and healthy returns amid rising natural gas demand. See more ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

Back in 2024, the city hired North Carolina-based Urban3, a firm of tax system experts, to analyze the town’s financial ...

The release of the 12-team College Football Playoff bracket sparked immediate debate across the sports landscape regarding who will eventually lift the trophy.

The new preferred stock offering, SATA, strengthens Strive’s capital options as it expands its bitcoin focused strategy.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Becoming a feng shui consultant isn't a conventional career path by any means, but this niche profession is far more ...

During your working years, it’s important to have cash savings for unplanned expenses. These could run the gamut from home ...

Convenience-store chain program offers easier credit approval with criteria that better fit the needs of new and growing ...

Herrington Management today announced the publication of an independent brief reviewing recent World of Hyatt points redemption patterns and planning considerations for award travel. The analysis ...

The issuance was arranged and promoted by Al Ahly Pharos, the investment arm of the National Bank of Egypt (NBE), and CI ...